Amsterdam UMC, location VUmc

NCT06923475

Phase 2/3Recruiting2026150 people11 Apr 2025clinicaltrials.gov

[18F]ACI-19626 PET in TDP-43 Proteinopathies

CollaboratorEarly phase 1Recruiting202545 people24 Mar 2025clinicaltrials.gov

NCT06687876

Phase 2Recruiting202514 people14 Nov 2024clinicaltrials.gov

NCT06220032

CollaboratorPhase 3Recruiting2024324 people23 Jan 2024clinicaltrials.gov

NCT05644301

CollaboratorPhase 3Recruiting2023240 people9 Dec 2022clinicaltrials.gov

NCT05493371

Phase 2Completed20238 people9 Aug 2022clinicaltrials.gov

NCT05415397

Phase 3Completed202294 people13 Jun 2022clinicaltrials.gov

NCT05210517

Phase 4Completed202010 people27 Jan 2022clinicaltrials.gov

NCT05182658

CollaboratorPhase 3Active, not recruiting2022250 people10 Jan 2022clinicaltrials.gov

NCT04392037

Phase 2Active, not recruiting202160 people18 May 2020clinicaltrials.gov

NCT04243850

Phase 4Withdrawn20200 people28 Jan 2020clinicaltrials.gov

NCT04238702

Phase 4Completed202024 people23 Jan 2020clinicaltrials.gov

NCT03797196

CollaboratorPhase 4Active, not recruiting2019374 people9 Jan 2019clinicaltrials.gov

NCT03509662

Phase 2Completed2019270 people26 Apr 2018clinicaltrials.gov

NCT03361098

Phase 4Completed201765 people4 Dec 2017clinicaltrials.gov

NCT03074630

Phase 4Completed201612 people9 Mar 2017clinicaltrials.gov

NCT02473562

Phase 4Terminated201322 people16 Jun 2015clinicaltrials.gov

NCT02455180

Phase 4Completed201520 people27 May 2015clinicaltrials.gov

NCT01744236

Phase 4Completed201370 people6 Dec 2012clinicaltrials.gov

NCT01254123

Phase 3Status unknown200940 people6 Dec 2010clinicaltrials.gov